Search results for " Combination"

showing 10 items of 923 documents

Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.

2012

BK virus (BKV)-induced viraemia after renal transplantation can be associated with severe impairment of graft function. This study evaluated possible risk factors for BKV replication and examined the outcomes following various currently used treatment approaches.Fifty-seven renal transplant recipients with BKV viraemia were retrospectively compared with 71 BKV-negative recipients to identify risk factors for BKV viraemia. Furthermore, outcome and graft function in 14 patients with BKV replication, in whom mycophenolate mofetil (MMF) was discontinued with a dose reduction of the remaining immunosuppressants, were compared with 32 patients in whom both MMF and the additional immunosuppressant…

NephrologyAdultMalemedicine.medical_specialtyvirusesUrologyLymphocytemedicine.medical_treatmentPrednisoloneAnti-Inflammatory AgentsKaplan-Meier Estimatemedicine.disease_causeVirus ReplicationGastroenterologyTacrolimusRisk FactorsInternal medicineConfidence IntervalsOdds RatioMedicineHumansLymphocyte CountWarm IschemiaRetrospective StudiesPolyomavirus Infectionsbusiness.industryGraft Survivalvirus diseasesImmunosuppressionOdds ratioMiddle AgedMycophenolic AcidViral LoadKidney TransplantationTacrolimusBK virusTransplantationTumor Virus Infectionsmedicine.anatomical_structureNephrologyBK VirusImmunologyCyclosporineDrug Therapy CombinationFemalebusinessViral loadImmunosuppressive AgentsScandinavian journal of urology and nephrology
researchProduct

Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind tri…

1982

A new combination of trimethoprim with a sulphonamide, named Kelfiprim, differs from cotrimoxazole in that: a) the sulpha drug is sulphamethopyrazine instead of sulphamethoxazole; b) the trimethoprim to sulpha ratio is 5:4 instead of 1:5;c) the presence of a long-acting sulphonamide allows the administration of a daily dose of one capsule, following an initial loading dose of two capsules; d) a reduced amount of trimethoprim is given, as compared to cotrimoxazole, without any decrease of efficacy. Kelfiprim [KP] was compared to contrimoxazole [Co] in a multicentre double blind trial. Sixty four patients suffering from acute and chronic infections of the upper and lower urinary tract entered…

NephrologyMalemedicine.medical_specialtySulfamethoxazoleUrologyUrinary systemUrineGastroenterologyLoading doseTrimethoprimDouble blindDouble-Blind MethodInternal medicineSulfanilamidesTrimethoprim Sulfamethoxazole Drug CombinationmedicineHumansClinical Trials as Topicbusiness.industrySulfaleneTrimethoprimSurgeryDrug CombinationsUrinary Tract InfectionsFemalebusinessmedicine.drugUrological research
researchProduct

HSP90 and eNOS partially co-localize and change cellular localization in relation to different ECM components in 2D and 3D cultures of adult rat card…

2007

Background information. Cultivation techniques promoting three-dimensional organization of mammalian cells are of increasing interest, since they confer key functionalities of the native ECM (extracellular matrix) with a power for regenerative medicine applications. Since ECM compliance influences a number of cell functions, Matrigel-based gels have become attractive tools, because of the ease with which their mechanical properties can be controlled. In the present study, we took advantage of the chemical and mechanical tunability of commonly used cell culture substrates, and co-cultures to evaluate, on both two- and three-dimensional cultivated adult rat cardiomyocytes, the impact of ECM c…

Nitric Oxide Synthase Type IIICell Culture TechniquesFluorescent Antibody TechniqueBiocompatible Materialslaw.inventionExtracellular matrixMicroscopy Electron TransmissionLamininConfocal microscopylawEnosAnimalsMyocytes CardiacHSP90 Heat-Shock ProteinsCellular localizationCells CulturedMatrigelMicroscopy ConfocalbiologyCell BiologyGeneral MedicineFibroblastsbiology.organism_classificationCoculture TechniquesCell biologyExtracellular MatrixFibronectinsRatsFibronectinDrug CombinationsProtein TransportCell culturebiology.proteinhsp90 ENOSProteoglycansCollagenLamininBiology of the cell
researchProduct

Integration of an LP Solver into Interval Constraint Propagation

2011

This paper describes the integration of an LP solver into iSAT, a Satisfiability Modulo Theories solver that can solve Boolean combinations of linear and nonlinear constraints. iSAT is a tight integration of the well-known DPLL algorithm and interval constraint propagation allowing it to reason about linear and nonlinear constraints. As interval arithmetic is known to be less efficient on solving linear programs, we will demonstrate how the integration of an LP solver can improve the overall solving performance of iSAT.

Nonlinear systemSatisfiability modulo theoriesDPLL algorithmLocal consistencyBoolean combinationInterval (mathematics)SolverAlgorithmMathematicsInterval arithmetic
researchProduct

An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.

2005

Summary Background : Alginate-based preparations act as mechanical antireflux barrier, which can reduce both acid and non-acid reflux events and limit the proximal migration of oesophageal refluxate. Aim : To evaluate all the above features with a novel technique, multichannel electrical impedance and pH-metry. Methods : Ten reflux patients underwent stationary impedancemetry and pH-metry after eating a refluxogenic meal. They were studied 1 h in basal conditions and 1 h after taking 10 mL of Gaviscon Advance. In both sessions, measurements were obtained in right lateral and supine decubitus. Results : Alginate preparation was able to decrease significantly (P < 0.05) the number of acid ref…

Novel techniqueAdultMalemedicine.medical_specialtySYMPTOMATIC TREATMENTACID REFLUXAlginatesSymptomatic treatmentSilicic AcidUrologySupine decubitusGASTROESOPHAGEAL-REFLUX DISEASEAluminum HydroxideGastric AcidPh metrymedicineHumansPharmacology (medical)Sodium alginateGASTROESOPHAGEAL-REFLUX DISEASE; SYMPTOMATIC TREATMENT; ACID REFLUXAgedHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyRefluxHydrogen-Ion ConcentrationMiddle Ageddigestive system diseasesSurgeryClinical PracticeDrug CombinationsSodium BicarbonateGastroesophageal RefluxDrug EvaluationFemaleAntacidsbusinessAlimentary pharmacologytherapeutics
researchProduct

Ab initio simulations on charged interstitial oxygen migration in corundum

2018

We have performed this work within the framework of the EUROfusion Consortium receiving funding from the European grant agreement 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission. Authors thank R. Vila, A.I. Popov, A. Luchshik and R.A. Evarestov for fruitful discussions. To carry out large-scale calculations, we have used the HPC supercomputer at Stuttgart University (Germany)

Nuclear and High Energy PhysicsMaterials scienceAb initiochemistry.chemical_elementCorundum02 engineering and technologyengineering.material01 natural sciences7. Clean energyMolecular physicsOxygenIonCondensed Matter::Materials ScienceHybrid DFT-LCAO calculationsCondensed Matter::Superconductivity0103 physical sciences:NATURAL SCIENCES:Physics [Research Subject Categories]010306 general physicsInstrumentationα-Al2O3(corundum sapphire)Charged oxygen interstitial diffusion021001 nanoscience & nanotechnologychemistryLinear combination of atomic orbitalsengineeringSapphireDensity functional theory0210 nano-technologyNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
researchProduct

Consistent searches for SMEFT effects in non-resonant dijet events

2018

We investigate the bounds which can be placed on generic new-physics contributions to dijet production at the LHC using the framework of the Standard Model Effective Field Theory, deriving the first consistently-treated EFT bounds from non-resonant high-energy data. We recast an analysis searching for quark compositeness, equivalent to treating the SM with one higher-dimensional operator as a complete UV model. In order to reach consistent, model-independent EFT conclusions, it is necessary to truncate the EFT effects consistently at order $1/\Lambda^2$ and to include the possibility of multiple operators simultaneously contributing to the observables, neither of which has been done in prev…

Nuclear and High Energy PhysicsParticle physicsTevatronFOS: Physical sciencesParameter space01 natural sciencesHigh Energy Physics - ExperimentStandard ModelHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)Perturbative QCD0103 physical sciencesEffective field theorylcsh:Nuclear and particle physics. Atomic energy. Radioactivity010306 general physicsLinear combinationPhysicsLarge Hadron Collider010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyEffective Field TheoriesTechnicolor and Composite ModelsObservableWeinberg angleHigh Energy Physics - PhenomenologyBeyond Standard Modellcsh:QC770-798Journal of High Energy Physics
researchProduct

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-…

2016

ObjectivesTo meta-analytically summarize lamotrigine’s effectiveness and safety in unipolar and bipolar depression.MethodsWe conducted systematic PubMed and SCOPUS reviews (last search =10/01/2015) of randomized controlled trials comparing lamotrigine to placebo or other agents with antidepressant activity in unipolar or bipolar depression. We performed a random-effects meta-analysis of depression ratings, response, remission, and adverse effects calculating standardized mean difference (SMD) and risk ratio (RR) ±95% confidence intervals (CIs).ResultsEighteen studies (n=2152, duration=9.83 weeks) in patients with unipolar depression (studies=4, n=187; monotherapy vs lithium=1, augmentation …

Olanzapinemedicine.medical_specialtyBipolar DisorderLithium (medication)Bipolar depressionBipolar depression bipolar disorder lamotrigine major depressive disorder trials unipolar depressionCitalopramLithiumCitalopramLamotrigineLamotriginePlaceboBipolar depression; bipolar disorder; lamotrigine; major depressive disorder; trials; unipolar depressionBenzodiazepines03 medical and health sciences0302 clinical medicineAntimanic AgentsFluoxetineInternal medicinemedicineHumansBipolar disorderunipolar depressionPsychiatryDepressive Disorder MajorFluoxetinemajor depressive disorderDepressionTriazinesbusiness.industrytrialsmedicine.diseaseAntidepressive Agents030227 psychiatryDrug CombinationsPsychiatry and Mental healthVitamin B ComplexMajor depressive disorderAnticonvulsantsNeurology (clinical)businessInositol030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drug
researchProduct

Vinblastine and interferon-alpha-2a regimen in the treatment of metastatic renal cell carcinoma.

1990

Thirteen patients with histologically proven advanced and/or metastatic renal cell carcinoma (RCC) were treated with vinblastine (Velbe, Eli Lilly, Sesto Fiorentino, Italy) and interferon-alpha-2a (Roferon-A, Roche, Milan). Eleven out of 13 patients were evaluable. Eighteen percent of patients had partial response, 46 % stable disease (SD), and 36 % progressive disease (PD). The mean survival of responders was 228+ days, whereas the patients showing SD and PD had a mean survival of 154+ and 107+ days respectively. Toxicity, including influenza-like syndrome, fever, neurological and gastrointestinal side effects, was generally mild. However, medication with paracetamol was required in 82 % …

OncologyAdultMaleCancer Researchmedicine.medical_specialtyInterferon alpha-2VinblastineGastroenterology03 medical and health sciences0302 clinical medicineStable DiseaseRenal cell carcinomaPartial responseInternal medicinemedicineHumans030212 general & internal medicineInterferon Alpha 2aCarcinoma Renal CellAgedbusiness.industryInterferon-alphaGeneral MedicineMiddle Agedmedicine.diseaseKidney NeoplasmsRecombinant ProteinsVinblastineRegimenOncology030220 oncology & carcinogenesisToxicityInterferon Type IDrug Therapy CombinationFemalebusinessProgressive diseasemedicine.drugTumori
researchProduct

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report

2018

Abstract Background The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored. Current options include new pituitary surgery and/or radiosurgery, or alternative medical treatment with SRLs high dose regimens, pegvisomant (PEG) as monotherapy, or combined therapy with the addition of PEG or cabergoline to SRLs. A new pharmacological approach includes pasireotide, a second-generation SRL approved for patients who do not adequately respond to surgery and/or for whom surgery is not an option. No reports on efficacy and safety of combined therapy with pasireotide and p…

OncologyAdultMalemedicine.medical_specialtyCabergolineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPegvisomant030209 endocrinology & metabolismCase ReportAntineoplastic Agentslcsh:Diseases of the endocrine glands. Clinical endocrinologyRadiosurgerySettore MED/13 - Endocrinologia03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCombined treatmentCabergolineInternal medicineAcromegalymedicineHumansErgolinesSalvage TherapyCotreatmentlcsh:RC648-665Medical treatmentSomatostatin receptorbusiness.industryHuman Growth HormoneGeneral Medicinemedicine.diseasePrognosisResistantPasireotideHormonesPasireotidechemistry030220 oncology & carcinogenesisPegvisomantAcromegalyDrug Therapy CombinationAcromegaly; Cotreatment; Pasireotide; Pegvisomant; ResistantbusinessSomatostatinmedicine.drugBMC Endocrine Disorders
researchProduct